Likewise, the detection of a tumor initiating cell (TIC) phenotype (evaluated with the expression of aldehyde dehydrogenase, CD133, and CD44) was associated with tumor recurrence and decreased DFS [145]. Here, PROM1 is linked to neoplasm.